New Delhi : Indian stocks have remained attractive for overseas investors, as foreign entities have pumped in over $19 billion so far — the second highest mark in a year. FIIs had pulled out USD 358 million (Rs 2,714 crore) in 2011.
But shares of multi-national companies (MNCs) will be in focus in the next few weeks as many of them will be required to either reduce promoter shareholding to a regulatory cap of 75% or get delisted.
At least four companies — Fresenius Kabi Oncology, Disa India, Blue Dart and Xchanging Solutions — have already sold promoter shares through one-day Offer for Sale (OFS) window in recent weeks, while a few others like Honeywell Auto too are lining up their share sales in due course. Under the offer-for-sale route, promoters can offload shares to any investor through a special window the exchanges allow for a day. Market analysts believes that more MNCs may opt for the OFS route to comply with Sebi’s norm as delisting is not a feasible option because of huge cost involved in it.
Barring two, Thomas Cook and Singer, shares of the Indian subsidiaries of foreign multinational firms have fallen in the range of 1-18 % in the last two months compared to the BSE index, Sensex, which has dipped by a little over 1% during the period. Individually, Astrazeneca Pharma dived by (18.43 %), followed by Fairfield Atlas (17.75 %), Sharp India (13.3 %), 3M India (8.75 %) and Oracle Financial Services (six %). Novartis, Gillette, BOC India, Elantas Beck India and Timken India too dropped on the bourses. — PTI
( To view our epaper please Tap here . For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)